SEC Form 4 · accession 0001104659-17-074880
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amarpreet Sawhney
Officer — Exec Chairman of the Board · Director · 10% Owner
Period of report
Dec 21, 2017
Accepted (ET)
Dec 22, 2017 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2017 | M | 83,011 | $2.49 | A | 779,401 | D | |
| Common Stock | Dec 21, 2017 | M | 106,382 | $2.73 | A | 885,783 | D | |
| Common StockF1 | holding | — | — | — | 846,377 | I | See Footnote | |
| Common StockF2 | holding | — | — | — | 471,784 | I | See Footnote | |
| Common StockF3 | holding | — | — | — | 379,419 | I | See Footnote | |
| Common StockF4 | holding | — | — | — | 71,969 | I | See Footnote | |
| Common StockF5 | holding | — | — | — | 189,393 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $2.49 | Dec 21, 2017 | M | 83,011 | D | — | Jan 30, 2023 | Common Stock | 83,011 | 0 | D |
| Stock Option (Right to Buy)F7 | $2.73 | Dec 21, 2017 | M | 106,382 | D | — | Jan 30, 2018 | Common Stock | 106,382 | 0 | D |
Explanation of responses
- F1The securities are directly held by Incept, LLC. The Reporting Person is a general partner of Incept, LLC. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
- F2The securities are directly held by the Sangam Trust. The Reporting Person and his immediate family members are beneficiaries of the Sangam Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
- F3The securities are directly held by the SAFIGS Trust. The Reporting Person's immediate family members are beneficiaries of the SAFIGS Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
- F4The securities are directly held by the Sawhney Family Dynasty Trust. The Reporting Person's immediate family members are beneficiaries of the Sawhney Family Dynasty Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
- F5The securities are directly held by the Amarpreet S. Sawhney 2014 GRAT. The Reporting Person and his immediate family members are beneficiaries of the Amar S. Sawhney 2014 GRAT. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
- F6This option was granted on January 31, 2013, and vested over four years with (i) approximately 24.7% of the shares underlying the option vesting on February 1, 2014, (ii) approximately 4.8% vesting monthly from March 1, 2014 to December 1, 2014, (iii) approximately 0.3% vesting on August 1, 2015, (iv) approximately 4.8% vesting monthly from September 1, 2015 to December 1, 2015, (v) approximately 3.7% vesting on November 1, 2016, and (vi) approximately 4.8% vesting on December 1, 2016.
- F7This option was granted on January 31, 2013, and vested over four years with (i) approximately 25.2% of the shares underlying the option vesting on February 1, 2014, (ii) approximately 3.7% vesting monthly from January 1, 2015 to July 1, 2015, (iii) approximately 3.5% vesting on August 1, 2015, (iv) approximately 3.7% vesting monthly from January 1, 2016 to October 1, 2016, (v) approximately 0.8% vesting on November 1, 2016, and (vi) approximately 3.7% vesting monthly from January 1, 2017 to February 1, 2017.